KOCAA
ABBV icon

Knights of Columbus Asset Advisors’s AbbVie ABBV Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Sell
1,391
-501
-26% -$108K 0.02% 324
2026
Q1 		$411K Sell
1,892
-31
-2% -$6.88K 0.02% 322
2025
Q4 		$439K Sell
1,923
-777
-29% -$177K 0.02% 316
2025
Q3 		$625K Buy
2,700
+1,480
+121% +$301K 0.04% 283
2025
Q2 		$226K Sell
1,220
-27
-2% -$5.02K 0.01% 303
2025
Q1 		$261K Sell
1,247
-161
-11% -$31.3K 0.02% 287
2024
Q4 		$250K Sell
1,408
-129
-8% -$23.7K 0.02% 292
2024
Q3 		$304K Buy
1,537
+31
+2% +$5.79K 0.02% 295
2024
Q2 		$258K Sell
1,506
-1,484
-50% -$246K 0.02% 326
2024
Q1 		$544K Buy
2,990
+1,073
+56% +$185K 0.04% 273
2023
Q4 		$297K Sell
1,917
-37
-2% -$5.39K 0.02% 297
2023
Q3 		$291K Buy
1,954
+46
+2% +$6.75K 0.03% 289
2023
Q2 		$257K Buy
1,908
+43
+2% +$6.31K 0.02% 304
2023
Q1 		$297K Sell
1,865
-79
-4% -$12.1K 0.03% 285
2022
Q4 		$314K Buy
1,944
+151
+8% +$23.2K 0.03% 274
2022
Q3 		$241K Sell
1,793
-122
-6% -$17.5K 0.02% 269
2022
Q2 		$294K Sell
1,915
-45
-2% -$6.88K 0.03% 261
2022
Q1 		$318K Sell
1,960
-3,091
-61% -$449K 0.03% 261
2021
Q4 		$684K Buy
5,051
+41
+0.8% +$4.84K 0.06% 239
2021
Q3 		$540K Buy
+5,010
New +$572K 0.05% 243

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Knights of Columbus Asset Advisors's ABBV Position: Q2 2026 in Review

Knights of Columbus Asset Advisors reduced its AbbVie (ABBV) stake by 26% in Q2 2026, selling an estimated $108K and leaving 1,391 shares worth $350K. The position accounts for 0.02% of the portfolio, ranked #324.

Knights of Columbus Asset Advisors first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. The position peaked at $684K in Q4 2021. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Knights of Columbus Asset Advisors held 1,391 shares of AbbVie worth $350K as of Q2 2026.
  • Knights of Columbus Asset Advisors sold 501 AbbVie shares in Q2 2026, an estimated $108K.
  • AbbVie made up 0.02% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #324 holding.
  • Knights of Columbus Asset Advisors first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
  • Knights of Columbus Asset Advisors's AbbVie position peaked at $684K in Q4 2021.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.